Get Involved
Help Shape The Future Of Managed Access
Participate in the Global Managed Access Benchmark
What are the priorities and opportunities for improvement
What is considered best practice
What are the priorities and opportunities for improvement
The Global Managed Access Benchmark (GMAB) is a new industry initiative bringing pharmaceutical leaders together together to build a clearer picture of how Managed Access is structured, governed and delivered globally.
We’re now inviting pharmaceutical companies and industry leaders to get involved.
Get Involved
Q4 2026: Help shape the research framework
Q1 2027: Review the proposed survey ahead of publication
Final discussion: Review anonymized findings and emerging conclusions
One approximately 20-minute survey
No company-level information shared; findings reported in aggregate
Your data remains confidential
No company-level information shared; findings reported in aggregate
Why GMAB
Why Participate?
Organizations taking part in GMAB will help create a new evidence base for Managed Access — while gaining insight into their own capabilities.
Participants will have the opportunity to:
Benchmark their approach
Understand how their Managed Access model compares with wider industry practice.
Identify strengths and opportunities
See where their organization demonstrates maturity and where further development may be valuable.
Learn from the industry
Gain insight into emerging operating models, practices and priorities.
Help define what good looks like
Contribute to the development of meaningful industry benchmarks for Managed Access.
Shape the research framework and methodology
Identify the issues that matter most to pharmaceutical companies
Ensure the benchmark reflects the realities of global Managed Access
Inform the interpretation of the findings
Contribute to the development of the inaugural GMAB report
Confidential By Design
We recognize that benchmarking Managed Access requires organizations to share information about their operating models, processes and capabilities.
Individual company responses will remain confidential.
Findings will be reported at an aggregated industry level, and no company or individual participant will be identified without explicit permission.
Help Create a Global View of Managed Access
Managed Access is becoming an increasingly important strategic capability for pharmaceutical companies.
GMAB is an opportunity for the industry to understand where we are today, learn from each other and help define where Managed Access goes next.
About GMAB
Take a personalized 15-minute tour
To request a demo, discuss your access challenges or learn more about Maprium, please use the secure form.